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Background: Enhanced attention has focused on contrast induced nephropathy among patients undergoing PCI. This study reports two-year trends 
in the rate of renal complications adjusted for Present On Admission (POA) flags among Medicare Beneficiaries (MB) undergoing PCI, in order to 
understand the group at risk.
Methods: A retrospective analysis was conducted on a study sample consisting of 668,718 Medicare Beneficiaries (MB) undergoing a PCI without 
CABG or valve surgery in FY 2009 + 2010. ICD-9-CM procedure and diagnosis codes were use to identify the outcomes of interest. POA flags were 
used to identify patient comorbidities that predisposed for ARF and new onset hemodialysis (newHD).
Results: The table indicates that MBs undergoing PCI were more likely to have both renal problems present on admission during FY-2010 than 
FY-2009. MBs were more likely to experience ARF complications and newHD in FY-2010 than FY-2009 among both the elective and non-elective PCI 
groups. NewHD is most likely in patients with severe CKD prior to the PCI. This is strongest in the elective population, whereas ARF on admission is 
more common in non-elective PCI patients.
Conclusion: This study identifies that ARF, including newHD, continues to rise in MB’s undergoing PCI. Further efforts to reduce this trend, especially 
in patients with CKD and/or concomitant ARF prior to PCI are warranted. 
2009 2010
Elective PCI
Medicare Beneficiaries 287,999 274,936
Patients Undergoing Dialysis 3,646(1.27%)
4,330
(1.57%)
Categories of Dialysis Patients
Prior History of Dialysis 19.91% 21.11%
New Onset Dialysis 80.19% 78.89%
Endstage Renal Failure POA 67.96% 68.22%
Endstage Renal Failure Complicaton 2.80% 1.76%
Acute Renal Failure POA 3.45% 3.72%
Acute Renal Failure Complication 3.18% 3.83%
No ARF or Endstage RF or History 2.61% 1.39%
Renal Failure (without dialysis)
Observed Acute Renal Failure (ARF) 5.66% 6.98%
Observed Endstage Renal Failure 2.55% 2.78%
Non-Elective PCI (Primary STEMI or Cardiogentic Shock) 2009 2010
Medicare Beneficiaries 51,392 54,391
Patients Undgoing Dialysis 325(0.63%)
401
(0.74%)
Categories of Dialysis Patients
Prior History of Dialysis 15.08% 13.97%
New Onset Dialysis 84.92% 86.03%
Endstage Renal Failure POA 56.31% 54.61%
Endstage Renal Failure Complicaton 3.08% 2.00%
Acute Renal Failure POA 10.15% 9.73%
Acute Renal Failure Complication 12.31% 18.20%
No AR or Endstage RF or History 3.08% 1.50%
Renal Failure (without dialysis)
Observed Acute Renal Failure (ARF) 10.87% 11.98%
Observed Endstage Renal Failure 1.46% 1.57%
